Your browser doesn't support javascript.
loading
Longitudinal whole-genome sequencing reveals the evolution of MPAL.
Zhang, Yu; Kang, Zhijie; Lv, Dekang; Zhang, Xuehong; Liao, Yuwei; Li, Yulong; Liu, Ruimei; Li, Peiying; Tong, Mengying; Tian, Jichao; Shao, Yanyan; Huang, Chao; Ge, Dongcen; Zhang, Jingkai; Bai, Wanting; Wang, Yichen; Liu, Quentin; Li, Zhiguang; Yan, Jinsong.
Affiliation
  • Zhang Y; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
  • Kang Z; The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
  • Lv D; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
  • Zhang X; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
  • Liao Y; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
  • Li Y; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
  • Liu R; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
  • Li P; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
  • Tong M; The First Hospital of Dalian Medical University, Dalian, Liaoning, China.
  • Tian J; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
  • Shao Y; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
  • Huang C; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
  • Ge D; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
  • Zhang J; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
  • Bai W; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
  • Wang Y; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
  • Liu Q; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China. Electronic address: liuq9@mail.sysu.edu.cn.
  • Li Z; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China. Electronic address: zhiguangli2013@126.com.
  • Yan J; The Second Hospital of Dalian Medical University, Dalian, Liaoning, China. Electronic address: yanjsdmu@126.com.
Cancer Genet ; 240: 59-65, 2020 01.
Article de En | MEDLINE | ID: mdl-31786363
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie aigüe biphénotypique / Protocoles de polychimiothérapie antinéoplasique / Variations de nombre de copies de segment d'ADN / Évolution clonale / Récidive tumorale locale Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Humans / Male Langue: En Journal: Cancer Genet Année: 2020 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie aigüe biphénotypique / Protocoles de polychimiothérapie antinéoplasique / Variations de nombre de copies de segment d'ADN / Évolution clonale / Récidive tumorale locale Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Humans / Male Langue: En Journal: Cancer Genet Année: 2020 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique